UMCG spinout CC Diagnostics has been backed by Carduso Capital as it moves closer to the launch of its cervical cancer screening technology.
CC Diagnostics, a Netherlands-based cancer diagnosis technology spinout from University Medical Center Groningen (UMCG), part of University of Groningen, has obtained an undisclosed sum from commercialisation firm Carduso Capital.
Carduso Capital manages a $35m fund called Carduso Capital Groningen NL that supports tech transfer from both UMCG and Groningen, though it did not explicitly name the fund as the investor in its press release.
In conjunction with Carduso’s investment, CC Diagnostics has also received a loan of undisclosed size…
